Singh Hardevinder Pal, Utreja Puneet, Tiwary Ashok Kumar, Jain Subheet
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, 147002, India.
AAPS J. 2009 Mar;11(1):54-64. doi: 10.1208/s12248-008-9078-8. Epub 2009 Feb 4.
Colchicine, an alkaloid found in extracts of the plants Colchicum autumnale and Gloriosa superb, is effective in the treatment of acute gout and dermatological conditions like leuko-cytoclastic vasculitis, psoriasis, and Sweet's syndrome. Oral administration of colchicine is associated with gastrointestinal side effects and its accumulation in the body leads to bone marrow suppression. In the present study, an attempt has been made for development and in vitro and in vivo evaluation of elastic liposomal formulation for topical delivery of colchicine. The in vitro skin permeation study across rat skin found transdermal flux for different elastic liposomal formulations to range between 32.8 +/- 1.2 and 44.4 +/- 1.9 microg h(-1) cm(-2), which was approximately seven to 11 times higher than obtained using drug solution (4.3 +/- 0.6 microg h(-1) cm(-2)). The results of skin deposition study showed that elastic liposomal formulation provide 12.5-fold higher skin deposition as compared to drug solution of colchicine. Confocal laser scanning microscopy also revealed better accumulation and deeper penetration (up to 200 microm) of elastic liposomes than drug solution (up to 12 microm). The biological evaluation of various vesicular formulations and drug solution was carried out using monosodium urate-induced air pouch model. The results of anti-gout activity in rats showed better and sustained biological effects in 24 h measured in terms of exudate volume (63.1 +/- 5.7% and 9.6 +/- 0.5% reduction with elastic liposomes and drug solution, respectively), reduction in leukocyte count (74.2 +/- 6.0% and 4.1 +/- 0.3% reduction with elastic liposomes and drug solution, respectively), decrease in inflammatory cells accumulation, and collagen deposition with elastic liposomal formulation than drug solution. Hence, the present study reveals that elastic liposomal formulation of colchicine possesses greater potential to enhance skin accumulation, prolong drug release, and improve the site-specificity of colchicine.
秋水仙碱是从秋水仙和嘉兰植物提取物中发现的一种生物碱,可有效治疗急性痛风和皮肤病,如白细胞破碎性血管炎、牛皮癣和斯威特综合征。口服秋水仙碱会产生胃肠道副作用,且其在体内的蓄积会导致骨髓抑制。在本研究中,已尝试开发用于秋水仙碱局部递送的弹性脂质体制剂并进行体外和体内评价。大鼠皮肤体外透皮研究发现,不同弹性脂质体制剂的透皮通量在32.8±1.2至44.4±1.9μg h⁻¹ cm⁻²之间,约为药物溶液(4.3±0.6μg h⁻¹ cm⁻²)的7至11倍。皮肤沉积研究结果表明,与秋水仙碱药物溶液相比,弹性脂质体制剂的皮肤沉积量高出12.5倍。共聚焦激光扫描显微镜还显示,弹性脂质体比药物溶液具有更好的蓄积和更深的渗透(高达200μm,药物溶液为高达12μm)。使用尿酸钠诱导的气袋模型对各种囊泡制剂和药物溶液进行了生物学评价。大鼠抗痛风活性结果显示,在24小时内,以渗出液体积衡量(弹性脂质体和药物溶液分别减少63.1±5.7%和9.6±0.5%)、白细胞计数降低(弹性脂质体和药物溶液分别减少74.2±6.0%和4.1±0.3%)、炎症细胞蓄积减少以及弹性脂质体制剂比药物溶液的胶原蛋白沉积减少方面,具有更好且持续的生物学效应。因此,本研究表明,秋水仙碱弹性脂质体制剂在增强皮肤蓄积、延长药物释放和改善秋水仙碱的位点特异性方面具有更大的潜力。